Uttar Pradesh Chief Minister Yogi Adityanath on Monday strongly rebutted allegations by Leader of the Opposition Mata Prasad Pandey over "deaths" due to consumption of fake medicines and codeine syrup, asserting in the Assembly that no such case has come to the notice of the state government so far.
He said that cases related to illegal diversion of the syrup were being pursued under the Narcotic Drugs and Psychotropic Substances (NDPS) Act and the state government had successfully defended its stand in court.
Replying to the issue raised by the opposition as soon as the House proceedings began, Adityanath said the matter appeared to be politically motivated.
"When an issue is raised unnecessarily, one is reminded of the saying 'Chor ke dadhi me tinka' (a guilty person feels the prick of straw in his beard)," he remarked.
The chief minister said "there is not a single case of death due to fake drugs reported in Uttar Pradesh till date," and added that enforcement agencies remain vigilant.
"From time to time, the Food Safety and Drug Administration (FSDA) conducts raids and takes strict action against erring firms," he said.
On codeine cough syrup, Adityanath categorically said, "There has been no death in Uttar Pradesh due to codeine syrup." "Cases related to illegal diversion of the syrup were being pursued under the NDPS Act and the state government had successfully defended its stand in court," the chief minister said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)